Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 1, 2007

Althea and Blueshift Combine Technologies for Gene Expression Screening

  • Althea Technologies and Blueshift Biotechnologies report that Althea received a SBIR award from the NHGRI to explore the potential for practical high-throughput and low-cost gene expression analysis.

    The grant proposes the development of gene expression profiling methods that make use of Althea's technology in multiplexed PCR (XP™-PCR)* methods and Blueshift's IsoCyte™ platform. This platform is a high-throughput laser scanner adapted from semiconductor inspection technology that provides multicolor fluorescence, anisotropy, and scatter images for high-content and object-based multiplexed array formats.

    The combined technologies may enable implementation of quantitative gene expression profiling in an automated high-throughput platform, providing highly specific and quantitative results for as many as 768 samples per minute.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »